Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
3 Must-Have Dividend Kings for a Steady Income Stream
08:09am, Tuesday, 12'th Mar 2024
In investing, where uncertainty often reigns high, dividend kings are the beacons of income stability and growth. Among them, three companies hold enduring leads.
Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What
06:21pm, Monday, 11'th Mar 2024
At first glance, another gangbusters jobs report seems to imply that dividend stocks are irrelevant. It's all about growth, baby!
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
09:28am, Monday, 11'th Mar 2024
Pfizer is a rebound candidate that pays a hefty dividend while you wait. AbbVie has been broadening its product offerings to become more diversified.
AbbVie: Comeback Expected After Humira Patent Expiration
12:23pm, Sunday, 10'th Mar 2024
AbbVie's full-year results for 2023 might have been weak, but its price is still up by 15% YTD. The disconnect is explained by the revenue dip because of patent expiration for its blockbuster drug Hum
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
02:46pm, Saturday, 09'th Mar 2024
Last year emerged as a time of unexpected resilience and expansion for the stock market driven by the strength of unstoppable mega-cap stocks. Notably, the S&P 500 wrapped up last year with a solid 24
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
02:59am, Saturday, 09'th Mar 2024
Both of these healthcare giants are leaders in their industries and faithful dividend payers. AbbVie is dealing with short-term challenges, but the strength of its underlying business remains intact.
Despite Humira's Challenges, AbbVie's Execution Makes It A Buy
02:27am, Saturday, 09'th Mar 2024
AbbVie is a leading pharmaceutical company with a diverse portfolio of products and strong revenue growth. The company has a solid track record of increasing dividends and offers an attractive current
AbbVie: Strong Cash Flow Growth Fuels Dividend Growth
05:21pm, Friday, 08'th Mar 2024
AbbVie is a pharmaceutical company with a strong history of growth and income generation for investors. The company has a robust pipeline of products in various stages of development, particularly in
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
12:46pm, Friday, 08'th Mar 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
AbbVie (ABBV) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Thursday, 07'th Mar 2024
AbbVie (ABBV) closed the most recent trading day at $180.57, moving -0.27% from the previous trading session.
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
02:43pm, Wednesday, 06'th Mar 2024
Dividend Aristocrats are a rare group of stocks. Not only do these members of the S&P 500 pay shareholders a dividend but in order to make the cut, they need to have raised their payout at least yearl
A total of 29 abstracts, including three late-breaking presentations, demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing science across a spectrum of immune-mediated dermatolog
The Top 7 Dividend Stocks to Buy in March 2024
06:17am, Wednesday, 06'th Mar 2024
Investors can effectively unlock financial freedom with dividend stocks to buy for a passive income stream. The key to invest in dividend stocks, promising a consistent and growing payout while offeri
AbbVie Inc. (ABBV) TD Cowen 44th Annual Health Care Conference (Transcript)
02:32pm, Tuesday, 05'th Mar 2024
AbbVie Inc. (NYSE:ABBV ) TD Cowen 44th Annual Health Care Conference Call March 5, 2024 9:10 AM ET Company Participants Rob Michael - President, Chief Operating Officer and Incoming CEO Jeff Stewart -
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
06:25am, Monday, 04'th Mar 2024
Investing in dividend kings is about keeping things simple. A distinguishing feature of these companies is a rock-solid balance sheet that allows them to demonstrate unwavering commitment to building
